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E-mail address: donatella.ferraro@unipa.it (D. FerrThe level of endemicity of hepatitis B virus (HBV) infections in Italy is low and genotype D infections pre-
dominant. New HBV strains may however be introduced as a result of movements of people from regions
of high endemicity. The aim of the present study was to determine whether strains from new cases of
acute hepatitis B detected in southern Italy were due to endemic or new HBV strains. We studied 34 iso-
lates from patients with acute hepatitis B infection, and 35 from chronic hepatitis B patients. A phyloge-
netic analysis of preS/S region was done by comparing the sequences from the acute and chronic cases
with references sequences. The study showed that 44% of strain from acute hepatitis B patients were
of genotype A, 53% of genotype D, and 3% of genotype E. The molecular analysis of isolates from acute
hepatitis B patients from Sicily showed a change in the local epidemiology of this infection, with an
increase in HBV/A infections and a clustering effect for HBV D2, possibly correlated to immigration.
The introduction of new genotypes , could have an effect on HBV-correlated diseases due to the different
association between genotype, liver disease and response to antiviral therapy.
 2012 Elsevier B.V. All rights reserved.1. Introduction
Hepatitis B virus (HBV) strains display great genetic heteroge-
neity as a consequence of their unique replication cycle and are
classiﬁed into eight genotypes (A–H) characterised by different
geographic distribution (Norder et al., 2002; Schaefer, 2007). Geno-
types A–D show such genetic diversity that they are divided into
subtypes (Makuwa et al., 2006; Tatematsu et al., 2009; Utsumi
et al., 2009). Genotypes A and D are distributed widely throughout
the world, with the A1 subtype prevailing in Africa and India, the
A2 subtype in northeast Europe and North America and genotype
D predominating in the Mediterranean basin.
The highly conserved S gene is best suited for discriminating
HBV isolates belonging to different genotypes and for study the
phylogenetic correlations between different strains by comparison
to sequences previously reported in Genbank (http://www.ncbi.
nlm.nih.gov/genbank/).
In Italy, HBV genotype D is responsible for 90% of chronic HBsAg
carriers, independent of whether they progress to liver disease or
not (Dal Molin et al., 2006). On the contrary, there are limited stud-
ies regarding the circulation of strains in new cases of HBV infec-
tion (Biliotti et al., 2008). Over the last 20 years, the endemicityll rights reserved.
alermo, Via del Vespro 133,
091/6553676.
aro).of HBV infections in Italy has shifted from an intermediate to low
(<2%) as a result of improving socioeconomic standards and of
the introduction of universal anti-HBV vaccination programs.
However, 1.3 cases of acute hepatitis B (AHB) per 100,000 persons
above the age of 25 were registered in 2005 (Mele et al., 2008). Dis-
placement of people from regions where HBV vaccination has not
been implemented universally, in combination with poor socioeco-
nomic conditions, can result in pockets of high endemicity in coun-
tries where incidence rates are otherwise low (Palumbo et al.,
2008). This scenario results in an increased risk of infection and
the introduction of HBV strains other than those prevalent to a spe-
ciﬁc region (Williams, 2006).
The aim of this study was to characterise HBV isolates collected
in Sicily, a region of southern Italy in the middle of Mediterranean
basin, to determine whether new cases of HBV infection were due
to endemic strains of HBV genotype D or to new HBV genotypes
introduced into this population.2. Materials and methods
2.1. Samples
Serum samples of 34 patients, enrolled consecutively with
symptomatic acute hepatitis B (AHB) referred to the GI and Liver
Unit at the University of Palermo and to the Infectious Disease Unit
at the University of Catania between July 2006 and October 2009,
Table 1
Risk factors associated with acute hepatitis B infections by subtype.
HBV Subtype Risk factors
Unsafe sex Tattoo Minor surgery IDUa Unknown
A1 – – – 1 –
A2 8 1 2 – 3
D1 10 2 1 – –
D3 – – 2 – 3
E 1 – – – –
Total 19 3 5 1 6
a IDU: intravenous drugs use.
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with AHB (32 men, two women; mean age 44, range 26–81 years)
32/34 were Sicilian. Self-reported risk factors for HBV included
promiscuous or unsafe sexual behaviours for 19 participants
(56%), recent tattooing for three (9%), minor surgical procedures
for ﬁve (15%), and intravenous drugs use for one (3%). Six patients
(17%) did not describe any evident exposures to risk factors associ-
ated with infection.
HBV strains from 35 Sicilian patients (27 men, eight women,
mean age 58, range 38–78 years) with untreated chronic hepatitis
B (CHB) and diagnosed over the previous 15 years, also seen at the
above clinics, were included as a control group.
The study protocol was approved by hospital’s Ethics Commit-
tee, and written consent for collection of clinical data and sequence
analysis of HBV–DNA was obtained from all patients.
2.2. HBV–DNA testing
Viral DNA was extracted using the High Pure Viral Nucleic Acid
Kit (Roche Diagnostics, Indianapolis, USA). Full-length HBV DNA
(3.2 kb) was ampliﬁed (Günther et al., 1995), using the Expand
High Fidelity PCR System (Roche Diagnostics). The ﬁrst-round
PCR product was ampliﬁed to obtain three overlapping fragments
covering the entire preS/S region in three different reaction
mixtures, with 800 nM of each primer (HBV1 50 GGTCACCA-
TATTCTTGGGAA 30 and HBV10 50 CCTGATGTGATGTTCTCCATG 30;
DON2 50 TCCACAACCTTCCACCAAACT30 and HBV2 50 AATGGC-
ACTAGTAAACTGAG 30; 377 50 GGATGTGCTTGCGGCGTTT 30 and
OS2 50 TCTCTGACATACTTTCCAAT 30).
2.3. Sequencing
The nucleotide sequence of the preS/S region was determined
by sequencing three overlapping fragments ampliﬁed by nested-
PCR. Approximately 15 ng of puriﬁed DNA were labelled by Big
Dye Terminator v 1.1 and analysed by a sequencer ABI Prism
3100 instrument (Applied Biosystems, Foster City, USA).
2.4. Sequence analysis
A consensus sequence of 1.3 kb corresponding to the preS/S re-
gion was generated by assembling the three partially overlapping
fragments with BioEdit software (Tom Hall, USA). Ambiguities
were resolved by sequencing both sense and antisense strands.
The preS/S sequences obtained were compared to sequences of
genotypes A (A1, A2,A4, A5, A6 subtype) and genotype D (D1, D2 ,
D4 and D6 subtype), published in GenBank (http://www.ncbi.
nlm.nih.gov/genbank).
All sequences were aligned based on viral genotype, using the
Clustal W algorithm and conﬁrmed by visual inspection. Phyloge-
netic trees and nucleotide difference matrixes were constructed
using the Mega 4.1 program using the Kimura two-parameter sys-
tem and the neighbour-joining method (NJ). Phylogenies were also
reconstructed using the maximum-likelihood method (ML), and
topologies conﬁrmed by both methods.
The mean synonymous (dS) and nonsynonymous (dN) substitu-
tion rates were estimated using the model of Nei and Gojobori with
the Jukes–Cantor correction with MEGA 4.1. The dN/dS ratios were
used to measure immune pressure selection.
2.5. Statistical analysis
Differences in the means between groups were compared using
an unpaired Student’s-t test. A p-value of <0.001 was considered
statistically signiﬁcant.3. Results and discussion
The study showed a high rate of HBV strains genotype non-D,
isolated from new cases of infection in Sicilian patients infected
mainly through unsafe sex. Indeed, HBV genotyping and subtyping
of the new strains, assessed by phylogenetic tree analysis (data not
shown), demonstrated that 15 (44%) were HBV genotype A (HBV/
A), 18 (53%) genotype D (HBV/D), and one genotype E (3%) (HBV/
E). The HBV/A strains identiﬁed were of subtype A1 (HBV/A1,
n = 1) and subtype A2 (HBV/A2, n = 14). The HBV/D strains identi-
ﬁed were subtype D1 (HBV/D1, n = 13), and subtype D3 (HBV/D3,
n = 5). The single genotype E strain identiﬁed was obtained from
a patient born in Ghana where the prevalence of HBsAg chronic
carriage is the highest in the world and genotype E strains are
dominant (95%) (Garmiri et al., 2009). Risk factors for HBV sub-
types are described in Table 1.
Most strains of subtype HBV/A2 was observed among patients
living in western Sicily.
Of the 35 strains from CHB patients enrolled, 33 (94%) were
HBV/D, of which 26 (78%) were HBV/D1, one (3%) HBV/ D2, six
(18%) HBV/D3 and two (5.7%) HBV/A2. This high prevalence of
the HBV/D genotype in CHB in Southern Italy has already been re-
ported (Mangia et al., 2008).
As a means of studying the phylogenetic correlations of the AHB
isolates, viral sequences obtained from the enrolled AHB patients
were compared to sequences from CHB patients and to reference
HBV sequences available in GenBank.
The single HBV/A1 isolate, found in the AHB group, segregated
with reference sequences from the Philippines and from India
(phylogenetic tree not shown) and was isolated from an intrave-
nous drug user patient who had a travel history to the Indian sub-
continent 2 months before the onset of hepatitis.
Eleven of the 14 HBV/A2 strains examined were isolated from
patients referred to Palermo (western Sicily) and all the HBV/A2
strains identiﬁed were grouped to the top of the phylogenetic tree
(Fig. 1). Within this group was observed one cluster, supported by a
94% bootstrap value, consisting of one sequence from one of two
Sicilian CHB/A2 patient and ﬁve sequences from AHB patients.
The results of phylogenetic analysis comparing to sequences from
a limited number of Sicilian CHB/A2 patient and sequences avail-
able in GenBank does not allow to trace a origin of these new iso-
lates. According to the promiscuous and unsafe sexual behaviour in
the most cases and the high endemicity of HBV/A2 in northeast
Europe allows to hypothesise that the HBV/A2 isolates could come
from these region.
HBV/D1 was the second most prevalent genotype detected
among AHB patients and the most prevalent among CHB cases.
Unlike HBV/A2, 11/13 HBV/D1 strains were obtained from patients
referred to Catania (Eastern Sicily). Among them, the main risk fac-
tor for HBV infection was also promiscuous and unsafe sexual
practices.
The phylogenetic tree of this subtype (Fig. 2) showed that the
sequences HBV/D1 from Sicilian CHB patients and from AHB
Fig. 1. Neighbor-joining tree of the preS/S region of HBV/A2 sequences using
boostrap values of 1000 replicates. The sequences from Sicilian patients presenting
with acute hepatitis B are preﬁxed by ‘‘h’’ and those with chronic hepatitis B by
‘‘j’’. The geographic location from where the reference sequences were obtained is
indicated to the right of the tree.
Fig. 2. Neighbor-joining tree of the preS/S region of HBV/D1 sequences using
boostrap values of 1000 replicates. The sequences from Sicilian patients with acute
hepatitis B infections are preﬁxed by ‘‘h’’ and those with chronic hepatitis B
infections by ‘‘j’’. The geographic location from where the reference sequences
were obtained is indicated to the right of the tree.
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Fig. 3. Neighbor-joining tree of the preS/S region of HBV/D3 sequences using Boostrap values of 1000 replicates. The sequences from Sicilian patients with acute hepatitis B
are preﬁxed by ‘‘h’’ and those with chronic hepatitis B are preﬁxed by ‘‘j’’. The geographic location from where the reference sequences were obtained is indicated to the
right of the tree.
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simultaneous circulation of endemic strains in our geographical
area.
Six HBV/D1 sequences from AHB patients segregated on the top
of the tree. The bootstrap value (<60%) of this group not support a
phylogenetic correlation of the strains. However, the nucleotide se-
quences analysis showed a similarity into the group with four sub-stitutions (G71A, G235A, G453A, A1190G) present only in these
isolates. Moreover, four of these six sequences result phylogeneti-
cally related, as supported by 92% bootstrap value. This sequences
derived from patients from Catania infected in the same year be-
cause of unsafe sex (23 CT e 33CT, bootstrap 68%) and tattoo
(26CT and 29 CT, bootstrap 95%). These date showed that four se-
quences might have an common source of infection.
Table 2
Nucleotide and amino acid matrix distances of PreS/S, ‘‘a’’ determinant and RT-
domain according to genotype and subtype from acute hepatitis B infected patients.
Region Genotype Subtype Genotype Subtype
D D1 D3 A A2
Nucleotide matrix distances
PreS/S 2.5 2.2 2.2 1.3 0.8
‘‘a’’ determinant 2.6 1.7 4.0 0.6 0.5
RT-domain 2.4 1.9 2.4 0.8 0.5
Amino acid matrix distances
PreS/S 3.2 2.8 4.1 1.4 1.4
‘‘a’’ determinant 3.7 3.5 8.1 0.0 0.0
RT-domain 3.2 2.5 3.7 0.86 0.8
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and two patients from Catania. The risk factor for three patients
was not identiﬁed, but minor surgery was established for two indi-
viduals. These HBV/D3 isolates formed a heterogeneous group with
six sequences from Sicilian CHB patients (Fig. 3). All ﬁve of the AHB
cases resulting from infections with HBV/D3 originated seemingly
from local viral isolates.
In order to study the genetic heterogeneity of viral isolates we
calculated the nucleotide and amino acid matrix distances of the
preS/S, the ‘‘a’’ determinant, and overlapping-RT domain, according
to genotype and subtype (Tables 2). D genotypes had a mean
nucleotide divergence signiﬁcantly greater than A genotypes
(p = 0.001). In particular, the ‘‘a’’ determinant showed a null amino
acid divergence in genotype A. This same condition was found,
even though the analysis was performed on the major subtypes.
Moreover, the D3 subtype had a higher value of divergence in
the S portion, and in the ‘‘a’’ determinant, compared with the D1
subtype, as previously described (De Maddalena et al., 2007;
Zehender et al., 2008).The study of amino acid sequences, evalu-
ated for each subtype, for the preS/S and RT regions, using the
model of Nei and Gojobori, showed that the mean synonymous
(dS) was always higher than nonsynonymous substitution (dN),
with a rate dN/dS < 1.
Amino acid characterization showed that the isolates come
from new infections did not have a common mutational pattern.
Antibody-escape mutants in the ‘‘a’’ determinant of the S gene,
and mutations in the overlapping P gene, associated with resis-
tance to antiviral drugs, were not observed. Similar ﬁndings were
reported in another study examining chronic HBV patients who
did not receive nucleos(t)ide analogues (Pollicino et al., 2009). This
absence may reﬂect the rarity of these viral mutants in reservoir of
chronic HBV carriers, their poor transmissibility rates or a weak
replicative potential which prevented these isolates from becom-
ing more highly prevalent.4. Conclusions
In Italy, HBV genotype D is responsible for 90% of chronic HBV
infection (Dal Molin et al., 2006). However, there are limited re-
ports regarding the epidemiology of new cases of acute hepatitis
B (Biliotti et al., 2008; Coppola et al., 2010) and characterization
by molecular means has yet to be carried out.
Studies in countries that have low incidence rates of HBV infec-
tions have demonstrated that immigration of individuals from
countries with high HBV endemicity resulted in the introduction
of HBV genotypes different from those endemic to the respective
host nations. For example, in Japan, where HBV/B and HBV/C are
the endemic genotypes, and in the Netherlands new AHB infections
with HBV/A genotype were shown to be on the rise (Matsuura
et al., 2009; Takeda et al., 2006; van Houdt et al., 2007).The high incidence of HBV/D genotype in Sicilian patients with
chronic infection, infected more than 15 years, it was associated
with the circulation of endemic strains transmitted mostly by int-
rafamilial spread, as previously demonstrated (Craxì et al., 1991).
Instead, phylogenetic analysis of viral isolates from new cases of
HBV infection showed the presence of A genotypes not endemic
in Sicily introduced mainly through sexual promiscuity and unsafe.
These data are in keeping with the ﬁndings of Coppola et al., who
recently described in Campania, another region of southern Italy,
an increase of genotype non-D HBV strains, isolated from new
cases of infection in the last 10 years, spread predominantly
through sexual transmission (Coppola et al., 2010).
HBV mutants able to elude vaccine-elicited protective immu-
nity were not found among Sicilian acute hepatitis B patients.
Hence in our area, where universal HBV immunisation programs
started since the late 80s, most acute cases of HBV infection are
attributable to infection with non-endemic HBV genotypes be-
cause of a increase of unsafe practices, mostly promiscuous sex,
among non-immune individuals.
The introduction of non-D genotypes could affect in the long
term the pattern of expression of HBV-related diseases due to
the variable association between genotype, liver disease and
response to antiviral therapy (Fung and Look, 2004).
Our study has identiﬁed HBV variants without immune escape
and drug resistant mutations, which could spread and prevail in
the population. This has been reported in a large outbreak of
HBV infection in the United Kingdom where two new variants of
A and D genotypes have spread in large population groups through
injecting drug use and heterosexual sex (Hallett et al., 2004;
Andersson et al., 2012).
It is worth noting that, since half of our patients with AHB were
infected by HBV genotype A and the reduction of viral load which
would theoretically be obtained by treating chronic HBV carriers
(most of them being infected by HBV genotype D) would change
only partially the circulation of HBV in our area. This is likely to
be due to the fact that the pool of chronic HBV carriers infected
by genotype A belong to a social-demographic setting (commercial
sex workers) which is not reached by screening for HBV.Acknowledgments
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